Hyperlipidemia due to hepatic triglyceride lipase deficiency: genes and variants
Explore variant evidence for Hyperlipidemia due to hepatic triglyceride lipase deficiency across 1 analyzed protein (LIPC). Linked ClinVar records include 1 pathogenic or likely pathogenic variants, 23 variants of uncertain significance and 5 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Hyperlipidemia due to hepatic triglyceride lipase deficiency
LIPC: Hepatic triacylglycerol lipase
It hydrolyzes triglycerides and phospholipids in HDL and remnant particles at the liver surface, helping remodel circulating lipoproteins. Loss-of-function variants can raise HDL cholesterol and alter remnant metabolism, with variable effects on atherosclerotic risk.
1 ClinVar pathogenic / likely pathogenic and 28 uncertain variants in LIPC have source records linked to Hyperlipidemia due to hepatic triglyceride lipase deficiency. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Hyperlipidemia due to hepatic triglyceride lipase deficiency
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| LIPC A195T | 195 | Pathogenic / likely pathogenic |
Diseases related to Hyperlipidemia due to hepatic triglyceride lipase deficiency
- Type 2 diabetes mellitus, also linked to LIPC
- Age related macular degeneration, also linked to LIPC
Frequently asked questions
Which genes have records linked to Hyperlipidemia due to hepatic triglyceride lipase deficiency?
This view contains 1 analyzed proteins: LIPC. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 1 pathogenic or likely pathogenic variants, 23 variants of uncertain significance and 5 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 35 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center